Investment Firm
Overview
Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.
Jan 01, 2020
Seed
Highlights
Location
Social
Investor Lead
N/A
Participant Investors
1
Investor Name |
---|
Lux Capital |
Cajal Neuroscience raised an undisclosed amount on 2020-01-01 in Seed Round
Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.
Company Funding History
2
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Jan 01, 2020 | Seed Round - Cajal Neuroscience | 1 | - | undefined |
Nov 29, 2022 | Series A - Cajal Neuroscience | 7 | - | 96.0M |
Recent Activity
There is no recent news or activity for this profile.